Astellas Pharma Ltd

Lovett House, Lovett Road, Staines, Middlesex, TW18 3AZ
Telephone: +44 (0)1784 419615
Fax: +44 (0)1784 419 401
Summary of Product Characteristics last updated on the eMC: 06/01/2006
SPC Cardene 20 and 30mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 06/01/2006 and displayed until Current
Reasons for adding or updating:
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 30/12/2003 and displayed until 06/01/2006
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 10 (date of (partial) revision of the text
Updated on 25/09/2003 and displayed until 30/12/2003
Reasons for adding or updating:
  • Change to joint SPC covering all presentations
Updated on 02/08/2002 and displayed until 25/09/2003
Reasons for adding or updating:
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 9 - Date of Renewal of Authorisation
  • Change to section 10 (date of (partial) revision of the text
  • Addition of Legal Category
Updated on 09/08/2001 and displayed until 02/08/2002
Reasons for adding or updating:
  • Correction of spelling/typing errors

Active Ingredients/Generics

 
   nicardipine


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk